Plazomicin activity against 346 extended-spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates in relation to aminoglycoside-modifying enzymes

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 2, 2017, Pages

  López Diaz, Maria Del Carmen ^a   Culebras, Esther ^a   Rodríguez Avial, Iciar ^a   Rios, Esther ^a   Viñuela Prieto, José Manuel ^a   Picazo, Juan J ^b   Rodríguez Avial, Carmen ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

AMEs; Aminoglycosides; ESBL; Escherichia coli; Plazomicin

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE MODIFYING ENZYME; BACTERIAL ENZYME; GENTAMICIN; PLAZOMICIN; TOBRAMYCIN; UNCLASSIFIED DRUG; 6'-(HYDROXYLETHYL)-1-(HABA)-SISOMICIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BETA LACTAMASE; SISOMICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DRUG ACTIVITY; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE AMPC PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; URINALYSIS; ANALOGS AND DERIVATIVES; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; URINARY TRACT;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; SISOMICIN; URINARY TRACT;

EID: 85011005408     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02454-16     Document Type: Article

References (19)

1. D'Andrea MM, Arena F, Pallecchi L, Rossolini GM. 2013. CTX-M-type beta-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol 303:305-317. https://doi.org/10.1016/j.ijmm.2013.02.008.
2. Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, Livermore DM. 2009. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob Agents Chemother 53:4472-4482. https://doi.org/10.1128/AAC.00688-09.
3. Ramirez MS, Tolmasky ME. 2010. Aminoglycoside modifying enzymes. Drug Resist Updat 13:151-171. https://doi.org/10.1016/j.drup.2010.08.003.
4. Karaiskos I, Souli M, Giamarellou H. 2015. Plazomicin: an investigational therapy for the treatment of urinary tract infections. Expert Opin Investig Drugs 24:1501-1511. https://doi.org/10.1517/13543784.2015.1095180.
5. U.S. National Institutes of Health. http://clinicaltrials.gov.
6. Coque TM, Oliver A, Perez-Diaz JC, Baquero F, Canton R. 2002. Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob Agents Chemother 46:500-510. https://doi.org/10.1128/AAC.46.2.500-510.2002.
7. Pérez-Pérez FJ, Hanson ND. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40:2153-2162. https://doi.org/10.1128/JCM.40.6.2153-2162.2002.
8. CLSI. 2009. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. CLSI document M100-S19. CLSI, Wayne, PA.
9. The European Committee on Antimicrobial Susceptibility Testing. 2013. Break-point tables for interpretation of MICs and zone diameters. Version 3.1. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-tables/Breakpoint-table-v-3.1.pdf.
10. Jensen VF, Jakobsen L, Emborg HD, Seyfarth AM, Hammerum AM. 2006. Correlation between apramycin and gentamicin use in pigs and an increasing reservoir of gentamicin-resistant Escherichia coli. J Antimicrob Chemother 58:101-107. https://doi.org/10.1093/jac/dkl201.
11. Akers KS, Chaney C, Barsoumian A, Beckius M, Zera W, Yu X, Guymon C, Keen EF, III, Robinson BJ, Mende K, Murray CK. 2010. Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex. J Clin Microbiol 48:1132-1138. https://doi.org/10.1128/JCM.02006-09.
12. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. 2006. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50:4114-4123. https://doi.org/10.1128/AAC.00778-06.
13. Díaz MA, Hernández-Bello JR, Rodríguez-Baño J, Martínez-Martínez L, Calvo J, Blanco J, Pascual A; Spanish Group for Nosocomial Infections (GEIH). 2010. Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study. J Clin Microbiol 48:2840-2845. https://doi.org/10.1128/JCM.02147-09.
14. Haldorsen BC, Simonsen GS, Sundsfjord A, Samuelsen O, Norwegian Study Group on Aminoglycoside Resistance. 2014. Increased prevalence of aminoglycoside resistance in clinical isolates of Escherichia coli and Klebsiella spp. in Norway is associated with the acquisition of AAC(3)-II and AAC(6′)-Ib. Diagn Microbiol Infect Dis 78:66-69. https://doi.org/10.1016/j.diagmicrobio.2013.10.001.
15. Galani I, Souli M, Daikos GL, Chrysouli Z, Poulakou G, Psichogiou M, Panagea T, Argyropoulou A, Stefanou I, Plakias G, Giamarellou H, Petrikkos G. 2012. Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece. J Chemother 24:191-194. https://doi.org/10.1179/1973947812Y.0000000015.
16. Walkty A, Adam H, Baxter M, Denisuik A, Lagace-Wiens P, Karlowsky JA, Hoban DJ, Zhanel GG. 2014. In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in Canadian hospitals as part of the CANWARD study, 2011-2012. Antimicrob Agents Chemother 58:2554-2563. https://doi.org/10.1128/AAC.02744-13.
17. Almaghrabi R, Clancy CJ, Doi Y, Hao B, Chen L, Shields RK, Press EG, Iovine NM, Townsend BM, Wagener MM, Kreiswirth B, Nguyen MH. 2014. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents. Antimicrob Agents Chemother 58:4443-4451. https://doi.org/10.1128/AAC.00099-14.
18. Fernández-Martínez M, Miró E, Ortega A, Bou G, González-López JJ, Oliver A, Pascual A, Cercenado E, Oteo J, Martínez-Martínez L, Navarro F; Spanish Network for the Research in Infectious Diseases (REIPI). 2015. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain. Int J Antimicrob Agents 46:157-163. https://doi.org/10.1016/j.ijantimicag.2015.03.008.
19. Xiao Y, Hu Y. 2012. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China. Microb Drug Resist 18:42-46. https://doi.org/10.1089/mdr.2010.0190.